1. Home
  2. BON vs ICCM Comparison

BON vs ICCM Comparison

Compare BON & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bon Natural Life Limited

BON

Bon Natural Life Limited

N/A

Current Price

$1.14

Market Cap

9.3M

Sector

Health Care

ML Signal

N/A

Logo IceCure Medical Ltd.

ICCM

IceCure Medical Ltd.

HOLD

Current Price

$0.96

Market Cap

8.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BON
ICCM
Founded
2006
2006
Country
China
Israel
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.3M
8.3M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
BON
ICCM
Price
$1.14
$0.96
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $22.67
AVG Volume (30 Days)
10.1K
★ 162.1K
Earning Date
09-23-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$385.87
$27.11
Revenue Next Year
$15.63
$104.97
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.95
$0.13
52 Week High
$2.06
$9.54

Technical Indicators

Market Signals
Indicator
BON
ICCM
Relative Strength Index (RSI) 45.27 22.37
Support Level $1.13 $0.96
Resistance Level $1.22 $2.50
Average True Range (ATR) 0.05 0.09
MACD -0.00 0.03
Stochastic Oscillator 57.79 39.22

Price Performance

Historical Comparison
BON
ICCM

About BON Bon Natural Life Limited

Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.

About ICCM IceCure Medical Ltd.

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Share on Social Networks: